Answers are grounded in this paper and cite their sources.
BACKGROUND: Mastectomy and its associated treatments may alter shoulder biomechanics and soft-tissue integrity, yet their impact on total shoulder arthroplasty (TSA) outcomes remains unclear. This study evaluated short- and long-term complications following TSA in patients with a history of mastectomy. METHODS: A retrospective cohort analysis was performed using the TriNetX Research Network, including patients who underwent primary TSA. Individuals with a history of mastectomy were identified using procedural and diagnostic coding, and those with contralateral mastectomy and TSA were excluded. Propensity score matching 1:1 was performed to balance demographics and comorbidities. Ninety-day and two-year outcomes were compared between matched cohorts. RESULTS: After matching, 1,865 patients with prior mastectomy were compared with 1,865 controls. Patients with a history of mastectomy had a significantly higher incidence of postoperative lymphedema (3.48% vs. 0.67%; RR 5.15; P < .0001). They also demonstrated increased risk of venous thromboembolism (4.56% vs. 3.11%; RR 1.47; P = .018). Overall postoperative infection rates were higher in the mastectomy cohort (3.96% vs. 2.70%; RR 1.47; P = .0378), including higher rates of cellulitis (2.81% vs. 1.72%; RR 1.63; P = .031). No significant differences were observed for 2-year outcomes. CONCLUSION: Patients with a history of mastectomy undergoing TSA are at increased risk of perioperative postoperative lymphedema, thromboembolic events, and cellulitis. These findings highlight the importance of heightened perioperative surveillance.
No takes yet. Share an insight, caveat, or question.
Adio et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: